Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monotherapy comparative trials: placebos and suboptimal comparators.

S Schwabe1

  • 1RW Johnson Pharmaceutical Research Institute, 920 Route 202, PO Box 300, Raritan, NJ 08869, USA. sschwabe@prius.jnj.com

Epilepsy Research
|July 20, 2001
PubMed
Summary

This study reviews comparative designs for epilepsy drug trials. Different methodologies, including placebo-controlled and monotherapy substitution studies, are evaluated for their effectiveness and limitations in demonstrating drug superiority.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histo-morphological effects on equine synovium after arthroscopic synovectomy using two different motorized synovial resectors and two different intensities.

Journal of equine veterinary science·2023
Same author

Inpatient monotherapy studies in epilepsy: pro.

Epilepsy & behavior : E&B·2003
Same author

The Neurotoxicity Scale: the validity of a patient-based scale, assessing neurotoxicity.

Epilepsy research·1995
Same author

Oxcarbazepine: clinical development program.

Epilepsia·1994
Same author

Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review.

Epilepsia·1994
Same author

Clinical development outlook of oxcarbazepine.

Epilepsia·1994

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Neurology

Background:

  • Demonstrating drug superiority in epilepsy requires robust comparative designs.
  • Traditional methods include placebo-controlled trials and monotherapy substitution studies.

Purpose of the Study:

  • To evaluate various comparative trial designs for assessing anti-epileptic drug (AED) efficacy.
  • To highlight the strengths and weaknesses of different methodologies in epilepsy research.

Main Methods:

  • Review of different comparative trial designs: placebo-controlled, low-dose, standard AED, monotherapy substitution, and enriched designs.
  • Analysis of patient populations: inpatients for presurgical monitoring, refractory epilepsy, and newly-diagnosed epilepsy.

Main Results:

Related Experiment Videos

  • Presurgical monitoring trials are short and may lack clinical relevance.
  • Monotherapy substitution studies offer direct comparison but require careful patient selection.
  • Enriched designs raise ethical concerns.
  • Trials in newly-diagnosed epilepsy need large patient numbers and long durations for significant results.

Conclusions:

  • No single comparative design is universally optimal for epilepsy drug trials.
  • The choice of design depends on the specific research question, patient population, and ethical considerations.
  • Careful consideration of trial duration, patient selection, and ethical implications is crucial for valid and relevant epilepsy drug research.